Loading…
NTRB
NutriBand Inc.
NASDAQ· Healthcare· Biotechnology· CUSIP 67092M208
$4.46-3.46%Price as of Aug 29, 18:43 UTC · updated once a day, after the close
Key metrics
- Market cap
- $54.22M
- P/E
- —
- Forward P/E
- —
- P/B
- 9.0x
- Dividend yield
- —
- Payout
- —
- EPS
- -$2.46
- ROE
- -145.72%
- Profit margin
- 0.00%
- Revenue growth
- -35.10%
- Beta
- 1.97
- 52-week high
- $8.63
- 52-week low
- $2.80
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▲ +49.0% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 6 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Year-end price | $8.00 | $4.54 | $4.71 | $2.32 | $3.61 | $8.64 | |
| P/S | 23.7x | — | 23.7x | 24.8x | 8.7x | 23.1x | 67.9x |
| P/B | 7.9x | — | 7.9x | 8.0x | 2.1x | 2.8x | 9.0x |
| EPS | -$2.58 |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| XTNTXtant Medical Holdings, Inc. | $0.38 | — | 1.3x | — | -25.16% | $53.87M |
| SCYXScynexis Inc | $5.39 | — | 0.8x | — | -18.38% | $53.63M |
| COCHEnvoy Medical, Inc. | $0.69 | — | 14.4x | — | — | $53.27M |
| BTMDbiote Corp. | $1.57 |
About the company
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
- Orlando, United States
Company description provided by Yahoo Finance.